Patient Story: Proton Therapy for Brain Tumor with Lindsay Strauss
Pregnant with her first child, Lindsay Strauss was diagnosed with a brain tumor and treated with proton therapy at Mass General Cancer Center.
Dr. William Curry is an attending in the Department of Neurosurgery and in the Pappas Center for Neuro-oncology. He provides surgical care for patients with benign and malignant tumors of the brain, skull-base, and spine.
Dr. Curry is a graduate of Harvard College, attended Cornell University Medical College in New York City and trained in Neurosurgery at Massachusetts General Hospital. He has been on the neurosurgical faculty at Mass General Hospital since 2004. He is a national leader in the neurosurgical care of patients with tumors of the brain, skull-base, and spine. He is highly skilled in both open and endoscopic/minimally invasive techniques and is known for his ability to handle the most advanced surgical challenges. Dr. Curry leads and participates in multiple clinical trials for patients with brain tumors and is particularly interested in the development of cellular and immune-based therapies for malignant tumors. He is an integral part of the Pappas Center for Neuro-oncology, the MGH/MEEI Cranial Base Center, and the Harris Chordoma Center at Massachusetts General Hospital.
Clinical Interests:
Treats:
Mass General Cancer Center: Neuro-Oncology
55 Fruit St.
Yawkey Center for Outpatient Care
Boston, MA 02114
Phone: 617-726-3779
Fax: 617-643-7928
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General has two proton therapy centers and is the only hospital in New England to offer proton therapy on site.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
Pregnant with her first child, Lindsay Strauss was diagnosed with a brain tumor and treated with proton therapy at Mass General Cancer Center.
A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment.
It’s fitting that the investigators who developed a new CAR T-based treatment for glioblastoma called their treatment platform “CAR-TEAM” cells, as it took a true team effort to bring their concept from the lab to the clinic.